
The US$4 billion merger of controversial ticket resale websites Viagogo and StubHub can proceed after the UK competition regulator approved a plan that will see StubHub’s international operations sold to a new entrant to the market, US investment group Digital Fuel Capital.
The Competition and Markets Authority (CMA) had ordered Viagogo to sell StubHub’s operations outside North America, after concluding that the combined entity would have handled about 90% of resold tickets for gigs, sports events, and theater in the UK.
Viagogo said Digital Fuel Capital, based in Newton, Massachusetts, had agreed to buy StubHub International for an undisclosed fee.
Digital Fuel Capital has largely invested in US businesses such as Rugs USA and artificial Christmas foliage firm National Tree Company, and describes its strategy as investing “at the intersection of analytics, art and technology.”
The business practices of Viagogo and StubHub have repeatedly come under scrutiny from the CMA and music industry groups, who have highlighted concerns about consumers being misled and their relationships with powerful touts accused of exploiting genuine fans.
The sale breathes new life into a merger that Forbes had called the “worst deal in history,” partly due to the CMA’s intervention, but largely because it was agreed just as the pandemic shut down live events globally.
It also completes a reunion of two businesses started by US entrepreneur Eric Baker, who co-founded StubHub before falling out with startup partner Jeff Fluhr.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
House Budget Bill’s Moratorium on State AI Laws Could Undo A Range of Tech Regs, Critics Say
May 14, 2025 by
CPI
Microsoft Nears EU Antitrust Resolution Over Teams Bundling, Sources Say
May 14, 2025 by
CPI
CMA Investigates Aviva’s £3.6B Acquisition of Direct Line Group
May 14, 2025 by
CPI
Google Urges Texas Judge to Disregard Virginia Antitrust Ruling
May 14, 2025 by
CPI
Anthropic Ordered to Respond After AI Allegedly Fabricates Citation in Legal Filing
May 14, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas